UPMC Arthritis and Autoimmunity Center, Falk Clinic
Welcome,         Profile    Billing    Logout  
 11 Trials 
20 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Amato, Anthony A
NCT06450886: Long-term Extension Study of Ulviprubart (ABC008) in Subjects with Inclusion Body Myositis

Active, not recruiting
2/3
270
US, RoW
Ulviprubart (ABC008)
Abcuro, Inc.
Inclusion Body Myositis (IBM)
01/29
04/29
NCT05721573: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Active, not recruiting
2/3
231
Europe, Canada, US, RoW
ABC008
Abcuro, Inc., Syneos Health
Inclusion Body Myositis
11/25
12/25
MAGiNE, NCT04231266: Multi-Center Study of ManNAc for GNE Myopathy

Active, not recruiting
2
54
US
ManNAc, N-acetyl-D-mannosamine monohydrate, Placebo
Leadiant Biosciences, Inc., Brigham and Women's Hospital, National Human Genome Research Institute (NHGRI), National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH (NIAMS and NIND) as part of NeuroNext
GNE Myopathy
05/25
10/25
INSPIRE-IBM, NCT05046821: Sporadic Inclusion Body Myositis Natural History Study

Active, not recruiting
N/A
150
US
University of California, Irvine, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Sporadic Inclusion Body Myositis, Inclusion Body Myositis
01/26
01/26
NCT05020002: Extracellular RNA Biomarkers of Myotonic Dystrophy

Recruiting
N/A
215
US
Massachusetts General Hospital, Beth Israel Deaconess Medical Center, University of Texas, Brigham and Women's Hospital
Myotonic Dystrophy
12/24
12/25
NCT05019625: Biomarker Development for Muscular Dystrophies

Recruiting
N/A
465
US
Massachusetts General Hospital, Boston Children's Hospital, Wake Forest University, University of Pittsburgh, Brigham and Women's Hospital
Myotonic Dystrophy, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy
06/26
06/27
Ascherman, Dana
NCT05721573: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Active, not recruiting
2/3
231
Europe, Canada, US, RoW
ABC008
Abcuro, Inc., Syneos Health
Inclusion Body Myositis
11/25
12/25
Domsic, Robyn
BLISSc-ILD, NCT05878717: A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Hourglass Jan 2021 - Jun 2021 : Submission in combination with rituximab for SLE
Recruiting
2/3
300
Europe, Japan, US, RoW
Belimumab, BENLYSTA™, GSK1550188, LymphoStat-B™, BENLYSTATM, GSK1550188, LymphoStat-B™, Placebo
GlaxoSmithKline
Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
07/27
07/27
CONQUEST, NCT06195072: Platform Clinical Study for Conquering Scleroderma

Recruiting
2
400
US
Amlitelimab, BI 1015550, Placebo
Scleroderma Research Foundation, Inc., Sanofi, Boehringer Ingelheim
Interstitial Lung Disease Due to Systemic Disease, Scleroderma
11/26
11/26
NCT03630211: Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

Recruiting
2
8
US
Cyclophosphamide, Mesna, Rituximab, Rituxan, Alemtuzumab, Campath-1H, Thiotepa, GM-CSF, Neupogen, Filgrastim, Intravenous immunoglobulin, Total Body Irradiation, Anti Thymocyte Globulin, Thymoglobulin
Paul Szabolcs
Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease, Pulmonary Hypertension
08/25
08/26
STSINJ, NCT06672822: Intralesional Injection of STS in Treatment of Calcinosis

Not yet recruiting
2
20
US
Sodium Thiosulfate (STS)
Robyn T. Domsic, MD, MPH, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Systemic Sclerosis (SSc), Dermatomyositis, Mixed Connective Tissue Disease (MCTD), Calcinosis
05/25
11/25
NCT04854850: Apollo Device for Fatigue in Systemic Sclerosis

Completed
N/A
25
US
Apollo, Apollo System, Tuned Vibrartory Stimulation
University of Pittsburgh, Apollo Neuroscience
Systemic Sclerosis, Fatigue, Raynaud Phenomenon
12/22
03/23
ASScERT-QoL, NCT06675344: The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

Recruiting
N/A
160
US
Apollo Neuro Device, Sham device
Robyn T. Domsic, MD, MPH, United States Department of Defense
Systemic Sclerosis (SSc)
03/28
09/28
Ivanco, Dana
WOMAN, NCT04344860: Prevent Postpartum Hemorrhage in Women with Von Willebrand Disease: the VWD- Trial

Completed
3
20
US
Recombinant Von Willebrand factor, rVWF, Vonvendi, Tranexamic Acid Injection [Cyklokapron], TA, Cyclokapron
Nicoletta C Machin
Von Willebrand Diseases, Postpartum Hemorrhage
08/24
09/24
AHAEmi, NCT05345197: Emicizumab in Patients With Acquired Hemophilia A

Recruiting
2
51
US
emicizumab, Hemlibra (R)
University of Washington, Genentech, Inc.
Acquired Hemophilia A
07/25
12/25
NCT04055051: ATHN 11: Liver Transplantation Outcomes Study

Completed
N/A
86
US
American Thrombosis and Hemostasis Network, BioMarin Pharmaceutical
Hemophilia A and B, Liver Transplantation
12/22
12/22
Abraham, Margaret
NCT05721573: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Active, not recruiting
2/3
231
Europe, Canada, US, RoW
ABC008
Abcuro, Inc., Syneos Health
Inclusion Body Myositis
11/25
12/25
Rodrigues, Raissa
NCT06450886: Long-term Extension Study of Ulviprubart (ABC008) in Subjects with Inclusion Body Myositis

Active, not recruiting
2/3
270
US, RoW
Ulviprubart (ABC008)
Abcuro, Inc.
Inclusion Body Myositis (IBM)
01/29
04/29
NCT05721573: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Active, not recruiting
2/3
231
Europe, Canada, US, RoW
ABC008
Abcuro, Inc., Syneos Health
Inclusion Body Myositis
11/25
12/25
NCT04886518: Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

Hourglass Jul 2022 - Dec 2022 : Efficacy and safety data for treatment of EDS in patients with Myotonic Dystrophy Type 1
Active, not recruiting
2
30
Canada, US
Pitolisant Oral Tablet, Placebo oral tablet
Harmony Biosciences, LLC
Myotonic Dystrophy 1, Excessive Daytime Sleepiness
10/23
10/24

Download Options